Stay up to date with our newsletter

Get in touch!

What can we do to help?

I would like to:

Lets start the conversation!

Sign up to our newsletter

View open positions on our Careers page,
or connect with us on Linkedin

Thank you!
We will be in touch shortly.


"The surge continues in pharmaceutical services” – C&EN report features Sai Life Sciences

The Chemical & Engineering News, arguably the world's most comprehensive and authoritative news source about chemistry and related fields, featured Sai Life Sciences in its report covering CPhI Worldwide 2019.
Observing the recent trend of contract manufacturing and development firms making transformative investments in their capabilities, C&EN takes the example of Sai Life Sciences, which is investing US $150 Mn in an unprecedented scale up of its facilities. Here’s an extract from the article:

“Another Indian company, Hyderabad-based Sai Life Sciences, is experiencing a growth surge with a near doubling of capacity this year and plans to boost it another 35% by mid-2021, according to CEO Krishna Kanumuri. The majority-family-owned firm also wants to double discovery services capacity in the next 12 months.
Investments are planned at labs in Manchester, England, and Cambridge, Massachusetts, and the firm is building a new research facility at its headquarters that will house 1,500 scientists when complete. Sai will invest $150 million between 2019 and 2023, Kanumuri said.
Behind the surge: “It’s just that our customers have grown,” he said. “We have helped along several companies that have launched molecules commercially over the last 5 years. You start slow, but once you establish yourself, the rate of growth goes up, and that’s where we are at this point.”



Global Business Reports interviews Krishna Kanumuri, MD & CEO Sai Life Sciences on the company’s journey of transformation

A recent edition of Global Business Reports (GBR) on India Pharmaceuticals 2019 features the interview with Krishna Kanumuri, MD & CEO of Sai Life Sciences. In the interview, Krishna provides a glimpse of the 20 years of the company, and how it is building itself for the future. Here’s an excerpt from the interview: “Sai […]
Read more


Sai Life Sciences turns 20!

For a company that started in a small laboratory with two fume hoods, Sai Life Sciences has come a long way in its quest of bringing new medicines to life. Over the past two decades, the company has enabled several innovator pharma and biotech customers discover, develop and manufacture innovative new medicines, and make the […]
Read more


Meet Sai Life Sciences at CPhI, Frankfurt

Sai Life Sciences will be in Frankfurt for CPhI worldwide during November 5-7, 2019. Whether you are a niche biotech firm or global pharma company, you will find a wide range of relevant services spanning the entire molecular life cycle to help your accelerate your NCE development. Please visit booth # 101B50 in Hall 10.1 […]
Read more


Sai’s new production block now open for business!

The brand-new API and Intermediate manufacturing facility (Block #8) at Sai Life Sciences is the company’s largest block in terms of volume and size. It marks a 70% increase in reactor volume taking the combined capacity past 400 KL.  The project was completed in an accelerated time-frame of 15 months and had the distinction of […]
Read more


We make your product development better through Technology platforms

From making your hazardous processes safer and simpler, to helping you develop greener and selective processes, we constantly put the newest technologies to use to make your product development better! Click here to know more about our technology platforms.
Read more